Literature DB >> 20004934

Defining the borders of splenic marginal zone lymphoma: a multiparameter study.

Scott D Dufresne1, Raymond E Felgar, Rachel L Sargent, Urvashi Surti, Susanne M Gollin, Ellen D McPhail, James R Cook, Steven H Swerdlow.   

Abstract

Classic splenic marginal zone lymphomas are CD5-, CD10-, CD23-, CD43-, and usually IgD+ with biphasic white pulp nodules. However, the 2008 World Health Organization classification accepts splenic marginal zone lymphomas with monophasic marginal zone-like white pulp nodules and recognizes a group of unclassifiable splenic small B-cell lymphomas. To explore the relationship of classic splenic marginal zone lymphomas to these other less well-defined splenic lymphomas, a multiparameter study of 47 splenic marginal zone lymphomas and unclassifiable splenic small B-cell lymphomas was performed. Seventeen of 31 splenic marginal zone lymphomas were biphasic, and 14 were monophasic (90%-100% marginal zone-like white pulp nodules). Sixteen cases were unclassifiable splenic small B-cell lymphomas, most lacking a marginal zone-type component. There were many clinical similarities between the 3 groups, including similar survivals. Monophasic and unclassifiable cases were less likely to have a typical splenic marginal zone lymphoma phenotype (28.6%, 23.1%) compared with biphasic cases (86.7%), usually because of IgD negativity (P < .003). Thirty-four of 42 (81%) cases had cytogenetic abnormalities by fluorescence in situ hybridization; and 17 of 20 (85%), by classical cytogenetics. The most frequent fluorescence in situ hybridization abnormalities among the splenic marginal zone lymphomas were del(7)(q31) (26%), +12 (25%), and +3q27 (27%); and among the unclassifiable cases, +12 (50%) and +3q27 (36%). Five of 6 unclassifiable cases with exclusively small non-marginal zone-like lymphocytes involving both white and red pulp had +12 compared with 9 of 34 other cases (P < .02). CDK6 (2 cases) and BCL3 (1 case) rearrangements were only seen in the unclassifiable group. These results support including both biphasic and monophasic cases as splenic marginal zone lymphomas, but suggest that the lack of a non-marginal zone-like population in the monophasic group is associated with some biologic differences. They also demonstrate a relatively large proportion of unclassifiable cases, including a group with frequent +12. Copyright 2010 Elsevier Inc.

Entities:  

Mesh:

Year:  2009        PMID: 20004934      PMCID: PMC2879876          DOI: 10.1016/j.humpath.2009.09.007

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  31 in total

1.  Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.

Authors:  M M Corcoran; S J Mould; J A Orchard; R E Ibbotson; R M Chapman; A P Boright; C Platt; L C Tsui; S W Scherer; D G Oscier
Journal:  Oncogene       Date:  1999-11-04       Impact factor: 9.867

2.  Atypical (7;19) translocation in acute myelomonocytic leukemia.

Authors:  M E Sherer; S Shekhter-Levin; J R Krause; R A Joyce; S M Gollin
Journal:  Cancer Genet Cytogenet       Date:  1991-12

3.  Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.

Authors:  F Solé; M Salido; B Espinet; J L Garcia; J A Martinez Climent ; I Granada; J M Hernández; I Benet; M A Piris; M Mollejo; P Martinez; T Vallespí; A Domingo; S Serrano; S Woessner; L Florensa
Journal:  Haematologica       Date:  2001-01       Impact factor: 9.941

4.  Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?

Authors:  M Mollejo; P Algara; M S Mateo; M Sánchez-Beato; E Lloret; M T Medina; M A Piris
Journal:  Histopathology       Date:  2002-01       Impact factor: 5.087

5.  Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.

Authors:  J M Hernández; J L García; N C Gutiérrez; M Mollejo; J A Martínez-Climent; T Flores; M B González; M A Piris; J F San Miguel
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

6.  Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32.

Authors:  Ronald Boonstra; Anneke Bosga-Bouwer; Gustaaf W van Imhoff; Vanessa Krause; Martin Palmer; Robert W Coupland; Laith Dabbagh; Eva van den Berg; Anke van den Berg; Sibrand Poppema
Journal:  Mod Pathol       Date:  2003-12       Impact factor: 7.842

7.  Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients.

Authors:  Jose I Chacón; Manuela Mollejo; Enriqueta Muñoz; Patricia Algara; Marisol Mateo; Luis Lopez; Jesús Andrade; Iciar García Carbonero; Beatriz Martínez; Miguel A Piris; Miguel A Cruz
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

8.  Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.

Authors:  Dong Chen; Mark E Law; Jason D Theis; Jeffrey D Gamez; Lynn B Caron; Julie A Vrana; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

9.  Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes.

Authors:  Josée Audouin; Agnès Le Tourneau; Thierry Molina; Sophie Camilleri-Broët; Colette Adida; Eva Comperat; Laurence Benattar; Alain Delmer; Alain Devidas; Bernard Rio; Jacques Diebold
Journal:  Br J Haematol       Date:  2003-08       Impact factor: 6.998

10.  Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia.

Authors:  S H Swerdlow; L J Murray; J A Habeshaw; A G Stansfeld
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

View more
  9 in total

1.  Splenic marginal zone lymphoma: hydra with many heads?

Authors:  Luca Arcaini; Marco Paulli
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2010-06-02       Impact factor: 0.196

3.  TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation.

Authors:  Jennifer Shrimpton; Matthew A Care; Jonathan Carmichael; Kieran Walker; Paul Evans; Charlotte Evans; Ruth de Tute; Roger Owen; Reuben M Tooze; Gina M Doody
Journal:  Blood Adv       Date:  2020-06-23

4.  MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Authors:  Fatima Hamadeh; Stephen P MacNamara; Nadine S Aguilera; Steven H Swerdlow; James R Cook
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

5.  Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier.

Authors:  Alba Navarro; Guillem Clot; Alejandra Martínez-Trillos; Magda Pinyol; Pedro Jares; Blanca González-Farré; Daniel Martínez; Nicola Trim; Verónica Fernández; Neus Villamor; Dolors Colomer; Dolors Costa; Itziar Salaverria; David Martín-Garcia; Wendy Erber; Cristina López; Sandrine Jayne; Reiner Siebert; Martin J S Dyer; Adrian Wiestner; Wyndham H Wilson; Marta Aymerich; Armando López-Guillermo; Àlex Sánchez; Elías Campo; Estella Matutes; Sílvia Beà
Journal:  Haematologica       Date:  2017-05-18       Impact factor: 9.941

6.  Unusual Course of Splenic Marginal Zone Lymphoma.

Authors:  Nay T Tun; Kaihong Mi; John Smith
Journal:  World J Oncol       Date:  2013-09-27

7.  Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.

Authors:  Jan Peveling-Oberhag; Franziska Wolters; Claudia Döring; Dirk Walter; Ludger Sellmann; René Scholtysik; Marco Lucioni; Max Schubach; Marco Paulli; Saskia Biskup; Stefan Zeuzem; Ralf Küppers; Martin-Leo Hansmann
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

Review 8.  A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma.

Authors:  Elif Yilmaz; Arashpreet Chhina; Victor E Nava; Anita Aggarwal
Journal:  Curr Oncol       Date:  2021-12-06       Impact factor: 3.677

Review 9.  CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.

Authors:  John J Schmieg; Jeannie M Muir; Nadine S Aguilera; Aaron Auerbach
Journal:  Curr Oncol       Date:  2021-12-04       Impact factor: 3.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.